QI
SCMP

QS Investors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

QS Investors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-108,513
Closed -$1.95M – 2014
2017
Q4 		$1.95M Sell
108,513
-5,309
-5% -$65.4K 0.02% 614
2017
Q3 		$1.34M Sell
113,822
-2,245
-2% -$25.2K 0.01% 733
2017
Q2 		$1.22M Hold
116,067
– – 0.01% 724
2017
Q1 		$1.28M Hold
116,067
– – 0.01% 729
2016
Q4 		$1.57M Sell
116,067
-22,633
-16% -$316K 0.01% 669
2016
Q3 		$1.71M Hold
138,700
– – 0.01% 679
2016
Q2 		$1.52M Sell
138,700
-109,800
-44% -$1.23M 0.01% 695
2016
Q1 		$2.72M Buy
248,500
+201,257
+426% +$2.54M 0.03% 568
2015
Q4 		$817K Buy
47,243
+45,650
+2,866% +$818K 0.01% 825
2015
Q3 		$32K Sell
1,593
-230,960
-99% -$5.29M ﹤0.01% 1343
2015
Q2 		$3.82M Buy
232,553
+86,743
+59% +$1.5M 0.05% 454
2015
Q1 		$2.27M Buy
145,810
+28,700
+25% +$445K 0.03% 573
2014
Q4 		$1.67M Buy
+117,110
New +$1.24M 0.02% 624

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

QS Investors's SCMP Position: Q1 2018 in Review

QS Investors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 108,513 shares — an estimated $1.95M sold.

QS Investors first reported a position in SCMP in Q4 2014 and held it in 13 quarters. The position peaked at $3.82M in Q2 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • QS Investors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • QS Investors sold 108,513 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.95M.
  • QS Investors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
  • QS Investors's Sucampo Pharmaceuticals, Inc. position peaked at $3.82M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.